PolyNovo (ASX:PNV) report $2.42 million loss for 1H
26 Feb 2020 - PolyNovo (ASX:PNV) reports a net loss for the half year of $2.42 million, that’s 26 per cent increase from last year.
26Feb
26Feb
Regis Healthcare (ASX:REG) see 50% drop in NPAT
26 Feb 2020 - Regis Healthcare (ASX:REG) report NPAT of $12.1 million for the first half of financial year 2020, down 50.5 per cent on the prior corresponding period.
26Feb
Renergen (ASX:RLT) natural gas and helium producer
26 Feb 2020 - Renergen Limited (ASX:RLT) Managing Director and CEO, Stefano Marani provides an update on recent drilling results at the company's Virginia Gas Project in South Africa, what’s planned for this year and the potential to bring forward a second production well.
26Feb
New coronavirus cases emerge as global stocks hit again: ASX set to open lower
26 Feb 2020 - The ASX looks set to open lower this morning as US stocks plunge. The global impact of the coronavirus outbreak continues to cause concern with South Korea now reporting near 1000 confirmed cases. European shares ended at their lowest in nearly two months. Healius (ASX:HLS) has received an unsolicited, non-binding indicative offer from a wholly-owned subsidiary of Partners Group.
26Feb
Universal Coal (ASX:UNV) to start legal proceedings regarding offer
26 Feb 2020 - Universal Coal (ASX:UNV) has started proceedings in the High Court of Justice of England and Wales in light of the unsolicited offer made by a wholly owned subsidiary of TerraComTCIG Resources.
26Feb
Michael Hill International (ASX:MHJ) see NPAT rise 19.6%
26 Feb 2020 - Jeweller Michael Hill International (ASX:MHJ) today announced its half year financial results period ending 29 December 2019 showing statutory net profit after tax increased by 19.6 per cent to $21.4 million, up from $17.9 million in the same corresponding period.
25Feb
Noxopharm (ASX:NOX) LuPIN trial in prostate cancer
25 Feb 2020 - Noxopharm Limited (ASX:NOX) Chief Medical Officer, Dr Gisela Mautner, talks about results from the company's LuPIN trial in prostate cancer, evaluating its lead product candidate, Veyonda, in combination with 177Lu-PSMA-617, a radiopharmaceutical therapy, in 56 patients with late-stage prostate cancer.
25Feb
Treasury Wine Estates (ASX:TWE) will not achieve growth guidance: Aus shares close 1.6% lower
25 Feb 2020 - The Australian share market today closed 1.6 per cent lower with Coronavirus fears dominating the sell-off. Treasury Wine Estates (ASX:TWE) believes it will not achieve previous growth guidance for the financial year.
25Feb
AUD hits 10-year low: Aus shares 1.3% lower at noon
25 Feb 2020 - The Australian share market plummeted at the open after the Dow plunged as Coronavirus fears grow. Blackmores to enter Indian market and launch pet supplements. Caltex (ASX:CTX) appoints interim CEO.
25Feb
Alumina (ASX:AWC) profit plunges as price dips
25 Feb 2020 - Alumina (ASX:AWC) today reported a statutory net profit after tax of US$214.0 million for the full-year to 31 December 2019, down 66 per cent.